Method for preventing or treating heart failure by administering a medicament containing an antagonist of corticotropin releasing hormone receptor 2 (CRHR2)

a technology of corticotropin and receptor 2, which is applied in the direction of cardiovascular disorders, drug compositions, peptides, etc., can solve the problems of inability to receive adequate social services, difficulty in going out of doors, and restricted daily lives of patients with heart failure, so as to achieve remarkable improvement in the therapeutic effect of heart failur
US20210379158A1Inactive Publication Date: 2021-12-09RAQUALIA PHARMA INC
1 Cites 0 Cited by

Patent Information

Authority / Receiving Office
US · United States
Patent Type
Applications(United States)
Current Assignee / Owner
RAQUALIA PHARMA INC
Publication Date
2021-12-09
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

A medicament for preventing or treating heart failure containing an antagonist of the corticotropin releasing hormone receptor 2 as an active ingredient.
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD

[0001] The present invention relates to a medicament for preventing or treating heart failure. More specifically, the present invention relates to a medicament for preventing or treating heart failure wherein the medicament contains an antagonist of the corticotropin releasing hormone receptor 2 as an active ingredient.BACKGROUND ART

[0002] The number of heart failure patients is very large since the number of patients with heart failure in the United States is about 6 million (American College of Cardiology, 2010) and the number of patients with heart disease in Japan is 1.7 million (Ministry of Health, Labor and Welfare, 2014). Patients with heart failure are restricted in their daily lives due to symptoms of heart failure such as short of breath and palpitations, and in particular elderly patients have difficulty in going out of doors due to symptoms of heart failure and often cannot receive adequate social services including medical care. Especially in Japan which is...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More